EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Screening Strategies Among High‐Risk Populations for Anal Cancer (ACCESS Study) Protocol

Raju Subbiah, Sohan Rodney Bangera, Nadi N Kaonga, Mary Grace Tadros, Isabella Rosa-Cuhna, Patricia Paule Jeudin, Kadera Jana Lymon, Nichole A Ciers-Davis, Annabel Reyes, Sakthivel Govindaraj, Monica T Garcia-Buitrago, C Christina Mehta und 9 weitere

Current Protocols · 2026-11 · 6 (11)

DOI: 10.1002/cpz1.70518 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Current Protocols, online erschienen am 11.11.2026. Verfasst von Raju Subbiah und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology and Immunology, Emory National Biomedical Research Center (ENBRC), Emory Vaccine Center, Emory University, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Anus Neoplasms, Early Detection of Cancer, Papillomavirus Infections. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, Emory National Biomedical Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anal cancer is a human papillomavirus (HPV)‐associated malignancy that disproportionately affects high‐risk populations, including people living with HIV, men who have sex with men, and women with a history of high‐grade lower genital tract neoplasia. Persistent infection with high‐risk human papillomavirus (hrHPV) is the primary cause of anal high‐grade squamous intraepithelial lesions (aHSIL), the precursor to anal cancer. Current screening approaches, including anal cytology and high‐resolution anoscopy (HRA), have important limitations related to diagnostic performance, cost, accessibility, and the availability of trained providers. There is a critical need for improved screening strategies and biomarkers capable of identifying individuals at greatest risk of persistent disease and progression.

Methods

The screening strategies among high‐risk populations for anal cancer (ACCESS) study is a prospective, multisite, longitudinal cohort study that will enroll 500 high‐risk adults from Emory University and the University of Miami. Participants will undergo annual screening for up to 2 years using anal cytology, hrHPV genotyping, CINtec®PLUS dual staining, HRA, and biopsy when indicated. Anal swabs, biopsies, and optional peripheral blood samples will be collected for molecular and immunologic analyses. DNA methylation markers, inflammatory biomarkers, immune profiling by multicolor flow cytometry, and single‐cell RNA sequencing will be evaluated to assess their association with aHSIL prevalence and clearance. Diagnostic performance measures, multivariable regression analyses, and biomarker‐based predictive models will be used to evaluate study outcomes.

Discussion

The ACCESS study will evaluate the performance of emerging screening biomarkers and characterize molecular and immune pathways associated with anal carcinogenesis in diverse high‐risk populations. By integrating clinical, epigenetic, immunologic, and environmental data, this study aims to improve risk stratification, identify biomarkers associated with persistent disease, and inform the development of more effective and targeted anal cancer prevention strategies. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anus NeoplasmsEarly Detection of CancerPapillomavirus InfectionsHumansMaleHuman Papillomavirus VirusesFemaleProspective StudiesAdult

Stichwörter der Autor:innen

HIVaHSILanal cancerhuman papillomavirusimmune profiling

Autor:innen und Institutionen

  • Division of Microbiology and Immunology, Emory National Biomedical Research Center (ENBRC), Emory Vaccine Center, Emory University, Atlanta, GA, USA.
  • Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA.
  • Raju Subbiah and Sohan Rodney Bangera contributed equally to this work and share first authorship.
  • Department of Gynecology and Obstetrics, School of Medicine, Emory University, Atlanta, GA, USA.
  • Department of Medicine, Division of Infectious Diseases, Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami, Leonard M. Miller School of Medicine, Miami, FL, USA.

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • Emory National Biomedical Research Center
  • NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Subbiah, R., Bangera, S. R., Kaonga, N. N., Tadros, M. G., Rosa-Cuhna, I., Jeudin, P. P., Lymon, K. J., Ciers-Davis, N. A., Reyes, A., Govindaraj, S., Garcia-Buitrago, M. T., Mehta, C. C., Galli, J. H., Potter, J. E., Peters, M., Smith, A. K., Ibegbu, C., Mosanjac, M., Velu, V., …, & Flowers, L. (2026). Screening Strategies Among High‐Risk Populations for Anal Cancer (ACCESS Study) Protocol. Current Protocols, 6(11). https://doi.org/10.1002/cpz1.70518

Vancouver

Subbiah R, Bangera SR, Kaonga NN, Tadros MG, Rosa-Cuhna I, Jeudin PP, et al. Screening Strategies Among High‐Risk Populations for Anal Cancer (ACCESS Study) Protocol. Current Protocols. 2026;6(11). doi:10.1002/cpz1.70518

BibTeX
@article{Subbiah2026,
  author = {Subbiah, Raju and Bangera, Sohan Rodney and Kaonga, Nadi N and Tadros, Mary Grace and Rosa-Cuhna, Isabella and Jeudin, Patricia Paule and Lymon, Kadera Jana and Ciers-Davis, Nichole A and Reyes, Annabel and Govindaraj, Sakthivel and Garcia-Buitrago, Monica T and Mehta, C Christina and Galli, Johnny H and Potter, JoNell E and Peters, Michaela and Smith, Alicia K and Ibegbu, Chris and Mosanjac, Marina and Velu, Vijayakumar and Xiao, Canhua and Flowers, Lisa},
  title = {Screening Strategies Among High‐Risk Populations for Anal Cancer (ACCESS Study) Protocol},
  journal = {Current Protocols},
  year = {2026},
  volume = {6},
  number = {11},
  doi = {10.1002/cpz1.70518}
}
Kostenlos starten →